Evaluation of strategies to improve influenza vaccination of patients with chronic kidney disease

Not Applicable

• Conditions: J10; N18.5; Z94.0; Z49.1; Influenza due to identified seasonal influenza virus; Chronic kidney disease, stage 5; Kidney transplant status; Extracorporeal dialysis

• Registration Number: DRKS00016558
• Lead Sponsor: niversitätsklinikum Schleswig-Holstein Campus Kiel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-06-30
• Study Start: 2019-01-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1217

Inclusion Criteria

Patient-centered intervention study:
All patients who received their kidney transplantation at the University Hospital Schleswig-Holstein (UKSH), Campus Kiel and are listed in the UKSH database in spring 2016, will be included in this study arm.

Insured Centered Intervention Study:
All insured persons of IKK Südwest, who had an indication for flu vaccination in the vaccination season 2015/2016 (01.10.2015 - 31.3.2016) were included into this study arm.

Physician-centered intervention study:
All nephrological contract doctors of North Rhine Association of Statutory Health Insurance Physicians.

Exclusion Criteria

none

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase of influenza vaccination rate.

Secondary Outcome Measures

Name	Time	Method
in the patient-centered study:<br>Attitude of chronically ill patients to a.) the danger of a flu infection, b.) influenza vaccine side effects